| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 01/08/2003 | EP1273289A1 Pharmaceutical compositions containing ascomycin derivatives |
| 01/08/2003 | EP1273288A1 Pharmaceutical compositions containing rapamycin derivatives |
| 01/08/2003 | EP1272907A2 Compliance tracking method |
| 01/08/2003 | EP1272670A2 Diagnosis of diseases associated with dna adducts |
| 01/08/2003 | EP1272635A1 Cryptic-like secreted protein |
| 01/08/2003 | EP1272518A2 Cd20/ige-receptor like molecules and uses thereof |
| 01/08/2003 | EP1272515A2 Immunoregulator |
| 01/08/2003 | EP1272514A1 Dna encoding human vanilloid receptor vr3 |
| 01/08/2003 | EP1272511A2 Molecules associated with human reproduction |
| 01/08/2003 | EP1272489A1 Process for preparing crystalline form i of cabergoline |
| 01/08/2003 | EP1272488A2 Tri-aryl-substituted-ethane pde4 inhibitors |
| 01/08/2003 | EP1272487A1 Bicyclic heteroaryl compounds as inhibitors of the interaction between the integrin alpha4beta1 receptor and vcam-1 and/or fibronectin |
| 01/08/2003 | EP1272484A2 Benzoamide piperidine compounds as substance p antagonists |
| 01/08/2003 | EP1272481A1 4-fluoroalkyl-2h-benzopyrans with anti-estrogenic activity |
| 01/08/2003 | EP1272470A1 Amorphous torasemide modification |
| 01/08/2003 | EP1272455A1 Halogenated 2-amino-4, 5 heptenoic acid derivatives useful as nitric oxide synthase inhibitors |
| 01/08/2003 | EP1272205A1 Sialoadhesin factor-2 antibodies |
| 01/08/2003 | EP1272204A2 Soft tissue and bone augmentation and bulking utilizing muscle-derived progenitor cells, compositions and treatments thereof |
| 01/08/2003 | EP1272201A2 Use of compatible solutes as substances having free radical scavenging properties |
| 01/08/2003 | EP1272184A2 Pharmaceutical compositions comprising salmeterol and ipratropium |
| 01/08/2003 | EP1272175A2 Il-8 receptor antagonists |
| 01/08/2003 | EP1272169A2 Use of 13-hode as a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia |
| 01/08/2003 | EP1272168A2 Small organic molecule regulators of cell proliferation |
| 01/08/2003 | EP1272162A1 Stabilized dry powder formulations |
| 01/08/2003 | EP1218407A4 Uses of kappa-conotoxin pviia |
| 01/08/2003 | EP1123276B1 N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them |
| 01/08/2003 | EP1119355B1 Naphthalenecarboxamides as tachykinin receptor antagonists |
| 01/08/2003 | EP0946175B1 USE OF A COMBINATION OF H+, K+ -ATPase INHIBITORS AND GLUCOCORTICOIDS IN THE TREATMENT OF NASAL POLYPS |
| 01/08/2003 | EP0817646B1 Methods of treating inflammation and compositions therefor |
| 01/08/2003 | EP0646012B1 WOUND HEALING AND TREATMENT OF FIBROTIC DISORDERS BY TGFbeta-3 |
| 01/08/2003 | CN1390256A Novel protein and DNA thereof |
| 01/08/2003 | CN1390255A Use of disease-associated gene |
| 01/08/2003 | CN1390222A Imidazole compounds used as phosphodiesterase VII inhibitors |
| 01/08/2003 | CN1390219A Pyrazolopyrimidines as therapeutic agents |
| 01/08/2003 | CN1390218A New active marine alkaloids |
| 01/08/2003 | CN1390137A A Blocking monoclonal antibody to VLA-1 and its use for the treatment of inflammatory disorders |
| 01/08/2003 | CN1390119A Process for making aqueous coated beadlets |
| 01/08/2003 | CN1389249A Chinese medicine with five functions of resisting bacterium, diminishing inflammation, relieving cough, relieving asthma and eliminating phlegm |
| 01/08/2003 | CN1389244A Rhinitis-treating clove ointment |
| 01/08/2003 | CN1389215A Hongbing ointment as one kind of locally administrated prepn. |
| 01/08/2003 | CN1389202A Levo-salbutamol hydrochloride aerosol and its prepn. |
| 01/08/2003 | CN1098264C Substituted 4-(1H-benzimidzol-2-yl-amino) piepridines useful for the treatment of allergic diseases |
| 01/08/2003 | CN1098259C Novel carboxy substituted cyclic carboxamide derivatives |
| 01/08/2003 | CN1098256C Substd. benzenesulfonamide derivatives as prodrugs of COX-2 inhibitors |
| 01/08/2003 | CN1098255C Novel substituted piperazine derivatives having tachyknin receptor antagonists activity |
| 01/08/2003 | CN1098096C Medicine for external application for curing rhinitis and its preparation method |
| 01/07/2003 | US6504034 Cell antiproliferative agents; anticancer agents |
| 01/07/2003 | US6503930 Pyrazole derivatives as p38 kinase inhibitors |
| 01/07/2003 | US6503910 Hydroxamic and carboxylic acid derivatives |
| 01/07/2003 | US6503908 Pharmaceutically active compounds |
| 01/07/2003 | US6503905 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives |
| 01/07/2003 | US6503713 Methods for identifying RNA binding compounds |
| 01/07/2003 | US6503542 Herbal compositions for treating immunological disorders |
| 01/07/2003 | US6503482 Non-chlorofluorocarbon aerosol formulations |
| 01/07/2003 | CA2075684C 1-acylpiperidine compounds |
| 01/06/2003 | CA2392288A1 Pharmaceutical preparation for the inhalation of antithrombin in anti-inflammatory lung diseases and ards |
| 01/05/2003 | CA2390181A1 Sulfonyl aryl triazoles as anti-inflammatory/analgesic agents |
| 01/03/2003 | WO2003000922A2 Chimeric immunomodulatory compounds and methods of using the same |
| 01/03/2003 | WO2003000896A2 POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-5 GENE |
| 01/03/2003 | WO2003000864A2 Nucleic acid-associated proteins |
| 01/03/2003 | WO2003000846A2 A novel g protein-coupled receptor, gave 3 |
| 01/03/2003 | WO2003000776A1 Biodegradable polyphosphoramidates for controlled release of bioactive substances |
| 01/03/2003 | WO2003000727A2 Atopy |
| 01/03/2003 | WO2003000699A1 Substituted 1-oxa-2,8-diaza-spiro[4,5]dec-2-ene derivatives as medicaments for the treatment of pain |
| 01/03/2003 | WO2003000697A1 Furoisoquinoline derivative, process for producing the same, and use |
| 01/03/2003 | WO2003000695A1 Pyrrolopyrimidines as protein kinase inhibitors |
| 01/03/2003 | WO2003000694A1 6-phenyldihydropyrrolopyrimidinedione derivatives |
| 01/03/2003 | WO2003000691A1 Carboline derivatives as pdev inhibitors |
| 01/03/2003 | WO2003000688A1 Azaindoles |
| 01/03/2003 | WO2003000687A1 Tyrosine kinase inhibitors |
| 01/03/2003 | WO2003000684A1 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (pai-1) |
| 01/03/2003 | WO2003000677A1 Spiropiperidine compounds as ligands for orl-1 receptor |
| 01/03/2003 | WO2003000671A1 Naphthyl benzofuran derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
| 01/03/2003 | WO2003000668A1 Oxa(thia)zolidine compounds, process for preparation thereof and anti-inflammatory agents |
| 01/03/2003 | WO2003000653A1 Substituted n-acyl aniline derivatives, production and use thereof as medicaments |
| 01/03/2003 | WO2003000323A1 Safety shield system for prefilled syringes |
| 01/03/2003 | WO2003000322A1 Safety shield system for prefilled syringes |
| 01/03/2003 | WO2003000289A1 Composition comprising a pde-4 inhibitor and h1-receptor antagonist and the use thereof for the manufacture of a medicament for the treatment of respiratory diseases |
| 01/03/2003 | WO2003000286A1 Remedies for eosinophilic diseases |
| 01/03/2003 | WO2003000265A1 Crystalline anticholinergic, method for its production, and use thereof in the production of a drug |
| 01/03/2003 | WO2003000264A1 Antihistamines for the treatment of nasal congestion and nasal obstruction |
| 01/03/2003 | WO2003000241A2 Novel pharmaceutical compositions based on anticholinergic agents, corticosteroids and betamimetic agents, for the treatment of inflammatory and/or obstructive respiratory tract diseases |
| 01/03/2003 | WO2003000240A2 Stable powder inhalation dosage formulation |
| 01/03/2003 | WO2003000238A1 Pharmaceutical compositions of adsorbates of amorphous drug |
| 01/03/2003 | WO2003000185A2 Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 |
| 01/03/2003 | WO2003000014A2 Spherical protein particles and methods of making and using them |
| 01/03/2003 | WO2002087605A3 Modified fvii in treatment of ards |
| 01/03/2003 | WO2002087596A3 Use of azithromycin for the manufacture of a medicament for treatment of non-infective inflammatory diseases |
| 01/03/2003 | WO2002083667A3 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 01/03/2003 | WO2002072584A3 Tetrahydro-pyrazino (1,2-a) indoles for the treatment of central nervous disorders |
| 01/03/2003 | WO2002060869A3 Use of p38 inhibitors for the treatment of inflammation-enhanced cough |
| 01/03/2003 | WO2002056915A3 Complex of modafinil and cyclodextrin |
| 01/03/2003 | WO2002046170A8 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto |
| 01/03/2003 | WO2002045702A3 Tricyclic therapeutics for chemokine mediated diseases |
| 01/03/2003 | WO2002026757A3 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
| 01/03/2003 | WO2002012501A3 Anti-dual integrin antibodies, compositions, methods and uses |
| 01/03/2003 | WO2002010387A3 G-protein coupled receptors |
| 01/03/2003 | WO2002009699A3 Method of treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract |
| 01/03/2003 | WO2002005842A3 Preventing airway mucus production by administration of egf-r antagonists |
| 01/03/2003 | WO2002002603A3 Protein modification and maintenance molecules |